AzTrials
AzTrials

AutismNCT06649916

Word Learning From Parentese in Autistic Children

A study testing Parentese Speech and Adult Registered Speech in people with Autism and Autism Spectrum Disorder, run by The University of Texas at Dallas at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3). Read more about this study

Who is it for?
Ages 18 to 59 monthsHealthy volunteers can take part
What is being tested?
Parentese Speech and Adult Registered Speech
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
4 Oct 2024to 1 Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • children with or without a diagnosis of ASD between 18 and 59 months

Who cannot join

  • hears another language more than 10% of time based on parent report
  • has uncorrected visual impairment or hearing impairment
  • has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pumpki L Su, PhD contact

972-883-2384

lei.su@utdallas.edu

McKenzie Cullinan, MS contact

mckenzie.cullinan@utdallas.edu

United States1 site, 1 recruiting
  • University of Texas at Dallas

    Richardson, Texas, 75080

    Pumpki L. Su, PhD, 973-883-2384, lei.su@utdallas.edu

    McKenzie Cullinan, MS, mckenzie.cullinan@utdallas.edu

    Recruiting

Other trials in United States

About this study

Official title: Autism Word Learning and Infant Directed-Speech

The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).

Read the detailed description

Caregivers frequently use parentese, also known as infant-directed speech (IDS), when speaking to young children. Compared to adult registered speech, parentese is typically characterized by greater pitch variation, longer duration, and louder volume. Parentese facilitates early language development in typically developing (TD) children. However, it remains unknown whether the facilitative effect of parentese on language learning can be generalized to clinical populations such as autistic children given that core autism features (e.g., sensory and social communication differences) may interact with how they process and learn from parentese. Most autistic children do not reach age-appropriate language ability even if they receive timely early intervention. Determining if autistic children can learn language from parentese, a common way language input is provided to young children, is a critical first step toward understanding whether language input needs to be adjusted to optimize their language development.

The overall objective of this research is to determine whether parentese facilitates novel word learning in autistic children and to investigate if the effect of parentese is conditional upon input factors (recorded parentese vs live parentese presented in social interaction) and child factors (extreme responses to auditory input, social motivation). In Aim 1, the investigators will use a video-based word learning paradigm to determine the effect of recorded parentese on novel word learning in autistic children compared to language-matched TD peers. Aim 2 focuses on the effect of live parentese on novel word learning: an experimenter will teach children two novel words, presented in live parentese or live parentese, during social interaction. Aim 3 will examine whether child factors (extreme responses to auditory input, social motivation) explain variability in word learning accuracy from recorded parentese and live parentese in the autistic group. Children's extreme responses to auditory input (including hyper- and hypo-responsiveness) and social motivation will be measured using caregiver questionnaires and will be used to predict word learning accuracy from recorded parentese (Aim 1) and live parentese (Aim 2) in the autistic group.

Being tested
Parentese Speech, Adult Registered Speech
Keywords
autism, word learning, language development
Medical subject headings
Autistic Disorder, Autism Spectrum Disorder, Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parentese SpeechBehavioural

    Also called Infant-Directed Speech

    Novel words are introduced in parentese, a type of speech that is typically characterized by greater pitch variation, longer duration, and louder volume

  • Adult Registered SpeechBehavioural

    Also called Adult-Directed Speech

    Novel words are introduced in standard adult register.

Study groups in NCT06649916
Study groupRoleWhat they receive
ParenteseExperimentalAll participants will learn novel words in two conditions (parentese vs adult register) in each of the experiment (video and live word learning). In the Parentese condition, participants will listen to sentences that contain novel words in parentese.
Receives: Behavioral: Parentese Speech
Adult RegisterActive comparatorAll participants will learn novel words in two conditions (parentese vs adult register) in each of the experiment (video and live word learning). In the Adult Register condition, participants will listen to sentences that contain novel words in adult register speech.
Receives: Behavioral: Adult Registered Speech

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of time during which children's eye gaze is directed toward the target object

    Children's eye gaze is recorded as they look at images. The proportion of time during which gaze is directed to an image of the targeted word is the dependent measure.

    Measured: 300 ms after the target words are introduced

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2024
  2. Study start4 Oct 2024
  3. Primary completion1 Mar 2028 (estimated)
  4. Study completion1 Mar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06649916
Sponsor's protocol ID
IRB-24-616
Other IDs
R21DC021803
Status last verified
Oct 2025
First submitted
17 Oct 2024
Last updated
23 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This was what was proposed in the study dissemination plan: Summary results of the primary outcomes for all aims will be uploaded to ClinicalTrials.gov within 12 months of the data collection for the final participants.

Questions about this trial

What is this clinical trial studying?

A study testing Parentese Speech and Adult Registered Speech in people with Autism and Autism Spectrum Disorder, run by The University of Texas at Dallas at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pumpki L Su, PhD (972-883-2384, lei.su@utdallas.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of time during which children's eye gaze is directed toward the target object (time frame: 300 ms after the target words are introduced). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in